Academia versus industry as a wellspring of new ideas in drug discovery : the case of oncology

The United States population is aging, and the need for novel approaches to treat and manage disease continues to grow. Among the diseases that will impact this population, cancer remains a therapeutic area with significant unmet need. Pharmaceutical and biotechnology industries must continue to meet revenue and income growth expectations and will become increasingly dependent on novel drugs in their pipelines. In order for the pharmaceutical and biotechnology industries to meet the demands of both patients and shareholders, productivity in the research and development process will need to improve significantly. In order to understand how best to improve the drug discovery and development process, it is important to identify potential sources of innovation throughout the process. Among these, an important consideration is to understand the paths that molecules take through the discovery and development process.

Department dc:contributor.department

Harvard University--MIT Division of Health Sciences and Technology.

Grantor dc:publisher

Massachusetts Institute of Technology

Year dc:date.issued

2006

Author dc:creator

• Conde, Jorge Cesar

Advisor dc:contributor.advisor

• Fiona Murray.

• Harvard University--MIT Division of Health Sciences and Technology.

Statement dc:rights

• M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.

Licence dc:rights.uri

• http://dspace.mit.edu/handle/1721.1/7582

Language dc:language.iso

eng

Handle dc:identifier.uri

http://hdl.handle.net/1721.1/35131

OAI identifier oai:identifier

oai:dspace.mit.edu:1721.1/35131